SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-15-001971
Filing Date
2015-07-31
Accepted
2015-07-31 13:06:04
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q medizone10q063015.htm 10-Q 380780
2 EX-31.1 ex31-1.htm EX-31.1 10981
3 EX-31.2 ex31-2.htm EX-31.2 10935
4 EX-32.1 ex32-1.htm EX-32.1 4311
5 EX-32.2 ex32-2.htm EX-32.2 4548
  Complete submission text file 0001185185-15-001971.txt   2041755

Data Files

Seq Description Document Type Size
6 EX-101.INS mzei-20150630.xml EX-101.INS 285231
7 EX-101.SCH mzei-20150630.xsd EX-101.SCH 25337
8 EX-101.CAL mzei-20150630_cal.xml EX-101.CAL 21333
9 EX-101.DEF mzei-20150630_def.xml EX-101.DEF 124922
10 EX-101.LAB mzei-20150630_lab.xml EX-101.LAB 191735
11 EX-101.PRE mzei-20150630_pre.xml EX-101.PRE 125920
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 151018766
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries